FR2736831B1 - NUCLEOTIDE AND PEPTIDE SEQUENCES FOR THE TREATMENT OF MYASTHENIA - Google Patents

NUCLEOTIDE AND PEPTIDE SEQUENCES FOR THE TREATMENT OF MYASTHENIA

Info

Publication number
FR2736831B1
FR2736831B1 FR9508736A FR9508736A FR2736831B1 FR 2736831 B1 FR2736831 B1 FR 2736831B1 FR 9508736 A FR9508736 A FR 9508736A FR 9508736 A FR9508736 A FR 9508736A FR 2736831 B1 FR2736831 B1 FR 2736831B1
Authority
FR
France
Prior art keywords
myasthenia
nucleotide
treatment
peptide sequences
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9508736A
Other languages
French (fr)
Other versions
FR2736831A1 (en
Inventor
Kaminsky Sylvia Cohen
Aknin Sonia Berrih
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR9508736A priority Critical patent/FR2736831B1/en
Priority to EP96926423A priority patent/EP0839195A1/en
Priority to PCT/FR1996/001131 priority patent/WO1997004093A1/en
Priority to JP9506367A priority patent/JPH11514968A/en
Publication of FR2736831A1 publication Critical patent/FR2736831A1/en
Application granted granted Critical
Publication of FR2736831B1 publication Critical patent/FR2736831B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9508736A 1995-07-19 1995-07-19 NUCLEOTIDE AND PEPTIDE SEQUENCES FOR THE TREATMENT OF MYASTHENIA Expired - Fee Related FR2736831B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR9508736A FR2736831B1 (en) 1995-07-19 1995-07-19 NUCLEOTIDE AND PEPTIDE SEQUENCES FOR THE TREATMENT OF MYASTHENIA
EP96926423A EP0839195A1 (en) 1995-07-19 1996-07-18 Nucleotide and peptide sequences for treating myasthenia
PCT/FR1996/001131 WO1997004093A1 (en) 1995-07-19 1996-07-18 Nucleotide and peptide sequences for treating myasthenia
JP9506367A JPH11514968A (en) 1995-07-19 1996-07-18 Nucleotide and peptide sequences for the treatment of myasthenia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9508736A FR2736831B1 (en) 1995-07-19 1995-07-19 NUCLEOTIDE AND PEPTIDE SEQUENCES FOR THE TREATMENT OF MYASTHENIA

Publications (2)

Publication Number Publication Date
FR2736831A1 FR2736831A1 (en) 1997-01-24
FR2736831B1 true FR2736831B1 (en) 1997-08-22

Family

ID=9481138

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9508736A Expired - Fee Related FR2736831B1 (en) 1995-07-19 1995-07-19 NUCLEOTIDE AND PEPTIDE SEQUENCES FOR THE TREATMENT OF MYASTHENIA

Country Status (4)

Country Link
EP (1) EP0839195A1 (en)
JP (1) JPH11514968A (en)
FR (1) FR2736831B1 (en)
WO (1) WO1997004093A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6464978B1 (en) * 1989-03-21 2002-10-15 The Immune Response Corporation Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populations
CA2068888A1 (en) * 1989-11-15 1991-05-16 Brian L. Kotzin Method for measuring t-cell surface antigens in humans
IE920447A1 (en) * 1991-02-12 1992-08-12 Roussel Uclaf NUCLEOTIDE SEQUENCES CODING FOR ß-CHAIN VARIABLE REGIONS OF¹HUMAN T-LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDE SEGMENTS¹AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
AU4762893A (en) * 1992-07-15 1994-02-14 Rijksuniversiteit Leiden Hla-dr3 blocking peptides and their use in the treatment of hla-dr3 associated autoimmune diseases.

Also Published As

Publication number Publication date
WO1997004093A1 (en) 1997-02-06
JPH11514968A (en) 1999-12-21
EP0839195A1 (en) 1998-05-06
FR2736831A1 (en) 1997-01-24

Similar Documents

Publication Publication Date Title
DE69612411T2 (en) Underwater treatment process and system
DE69608448T2 (en) REDUCTION OF BIOLOGY
PL324218A1 (en) Improved surface treatment of polymers
MA23941A1 (en) TISSUE TREATMENT
BR9609797A (en) Inhibition of gene expression
FI956339A (en) Treatment of absence of hypothalamic menstruation
BR9609726A (en) Inhibition of gene expression
DE19681419T1 (en) Treatment system
ATE226922T1 (en) WASTEWATER TREATMENT SYSTEM
EP0761692A3 (en) Removal of liquid from pullulan
GB9503794D0 (en) Treatment of fabrics
FR2740454B1 (en) PEPTIDES CAPABLE OF INHIBITING APP ENDOCYTOSIS AND CORRESPONDING NUCLEOTIDE SEQUENCES
FR2694384B1 (en) Surface treatment of refractories.
DE59605608D1 (en) Process for the preparation of 2-fluorophenyl hydrazine
MA23837A1 (en) BENZAMIDES FOR THE TREATMENT OF NEUROLOGICAL DEGENERES
HUP9802834A3 (en) Preparations for the treatment of t cell mediated autoimmune diseases
GB9526218D0 (en) DNA Sequences
NO973366D0 (en) Procedure for the treatment of multiple sclerosis
FR2736831B1 (en) NUCLEOTIDE AND PEPTIDE SEQUENCES FOR THE TREATMENT OF MYASTHENIA
FR2751637B1 (en) ELECTROCOAGULATION CELL FOR THE TREATMENT OF EFFLUENTS
FR2769013B1 (en) TREATMENT OF CURAGE SLUDGE
ZA9610478B (en) Process for the purification of recombinant human interleukin-8
FR2749512B1 (en) USE OF ACETYL DL LEUCINE FOR TREATING TREMENTS
DZ1915A1 (en) New opioid peptides for the treatment of pain and their use.
MA23648A1 (en) NOVEL OPIOID PEPTIDES FOR THE TREATMENT OF PAIN AND THEIR USE

Legal Events

Date Code Title Description
ST Notification of lapse